ACS Exec Exits After Projecting $40-Million Revenue Slump
Last summer the
The society stated in a press release at that time that adding MacMaster to the "seminal post" was "... part of a transformative effort designed to save even more lives from cancer."
Less than 18 months later that executive is gone, and the ACS is facing a projected $40-million revenue loss linked to an especially poor showing from its hallmark
events.
Source: MedPage Today
Read the full story:
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Related Articles
- Metabolic Issues More Common in Patients With HIV
September 18th 2025
- Barriers to Gender-Affirming Surgery Persist Despite High Satisfaction Rate
September 18th 2025
- Eating Behaviors May Predict GLP-1 Therapy Success in Type 2 Diabetes
September 18th 2025